Kuan-Hsun Wang

Title: Kuan-Hsun Wang: Innovator in Pharmaceutical Crystallization

Introduction

Kuan-Hsun Wang is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of drug crystallization. With a total of 3 patents to his name, Wang's work has implications for the development and manufacturing of important pharmaceutical compounds.

Latest Patents

Wang's latest patents include a novel crystalline form of olaparib and a process for preparing the same. This invention provides a unique crystalline form of olaparib, which is crucial for its efficacy and stability. The process involves forming a solution of crude olaparib and an organic solvent, followed by the addition of an anti-solvent to create a slurry. The precipitate is then isolated and dried to obtain a crystalline form III of olaparib. Another significant patent involves crystalline forms of pemetrexed diacid, which are produced for both laboratory and industrial scales. The processes for preparing these forms are also detailed in his patents.

Career Highlights

Throughout his career, Kuan-Hsun Wang has worked with reputable companies such as Scinopharm Taiwan Ltd. and Scintopharm Taiwan Ltd. His experience in these organizations has allowed him to refine his expertise in pharmaceutical development and crystallization techniques.

Collaborations

Wang has collaborated with notable colleagues, including Wen-Wei Lin and Ying-Tzu Lin. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Kuan-Hsun Wang's innovative work in the field of pharmaceutical crystallization has led to the development of important patents that enhance drug formulation processes. His contributions continue to impact the pharmaceutical industry positively.